Attending physician, at Jingzhou Central Hospital, China.
Dr. Xuanxuan Xu is an attending physician at Jingzhou Hospital Affiliated to Yangtze University, China. She holds a Master’s degree from Anhui Medical University and has dedicated her career to hematology research, focusing on immune mechanisms. With extensive experience in clinical practice and scientific research, Dr. Xu has led and contributed to multiple projects at both national and municipal levels. She has published several high-impact papers in SCI-indexed journals, including groundbreaking research on immune cells in COVID-19 patients, which has been widely cited. Dr. Xu is also actively involved in collaborations and professional memberships, advancing innovations in hematological disorders.
Professional Profile
Scopus
ORCID
🎓 EducationÂ
Dr. Xuanxuan Xu earned her Master’s degree from Anhui Medical University, a prestigious institution known for its contributions to medical sciences. Her academic journey was marked by a strong focus on hematology and immunology, equipping her with deep expertise in the immune mechanisms of blood disorders. During her studies, she gained hands-on experience in clinical diagnostics, laboratory research, and advanced immunological techniques. Her thesis focused on the role of immune cells in hematological diseases, paving the way for her future research endeavors. After completing her Master’s, she continued her professional training at Jingzhou Hospital Affiliated to Yangtze University, where she integrated her academic knowledge with real-world medical challenges. Dr. Xu remains committed to continuous learning, attending international conferences and specialized training programs to stay at the forefront of medical advancements.
đź’Ľ ExperienceÂ
Dr. Xuanxuan Xu has built an impressive career as an attending physician at Jingzhou Hospital Affiliated to Yangtze University. With years of experience in clinical hematology and immunology research, she has played a key role in diagnosing and treating patients with blood disorders. Her expertise extends beyond clinical work—she has led two municipal research projects and actively contributed to a National Natural Science Foundation project. In 2020, she made a significant impact by being among the first to publish studies on immune cell responses in COVID-19 patients, influencing global research efforts. Dr. Xu is also engaged in medical education, mentoring young physicians and guiding research initiatives. She collaborates with leading hematologists and immunologists, ensuring her findings translate into better patient care and innovative treatments. Her experience reflects a perfect balance of clinical practice, academic research, and leadership in medical advancements.
🔬 Research InterestsÂ
Dr. Xuanxuan Xu’s research primarily focuses on hematology and immune mechanisms. She explores the interplay between immune cells and blood disorders, particularly in conditions like iron deficiency anemia and autoimmune hematological diseases. Her work aims to uncover new diagnostic biomarkers and therapeutic strategies for improving patient outcomes. One of her key research contributions is the gene prediction of immune responses in anemia, providing valuable insights for future treatments. Additionally, she has contributed to studies on immune system responses in COVID-19 patients, significantly advancing global knowledge in this area. Dr. Xu’s current projects involve genomic and proteomic analyses of hematological disorders, leveraging cutting-edge bioinformatics tools. Her passion for translational medicine drives her to bridge laboratory discoveries with clinical applications, ultimately enhancing precision medicine in hematology. She actively collaborates with national and international researchers, ensuring her work remains at the forefront of medical innovations.
🏆 AwardsÂ
Dr. Xuanxuan Xu has received multiple accolades for her contributions to hematology and immune research. She was nominated for the Best Researcher Award, recognizing her groundbreaking work on immune cell interactions in anemia and COVID-19. Her research has been widely cited, demonstrating its impact in the medical community. In addition to her individual achievements, she has been recognized by municipal and national research institutions for her leadership in hematology projects. In 2020, her study on immune cell profiles in COVID-19 patients was acknowledged for its significance in shaping pandemic-related hematology research. Dr. Xu has also been invited as a keynote speaker at several international medical conferences, further highlighting her expertise. Her dedication to advancing medical science has positioned her as a leading figure in hematological immunology, inspiring young researchers and medical professionals worldwide.
đź“š Top Noted Publications
Dr. Xuanxuan Xu has published multiple high-impact papers in SCI-indexed journals, contributing valuable insights to hematology and immune research. Her most notable work includes:
-
Xu X, Li Z, Liu H, Huang Z, Xiong T, Tang Y. (2025)
- Title: Gene prediction of the relationship between iron deficiency anemia and immune cells
- Journal: Hematology
- Volume & Issue: 30(1)
- DOI: 10.1080/16078454.2025.2462857
- Citations: 15 articles
- Summary: This study explores the genetic links between iron deficiency anemia and immune cell function, highlighting specific gene markers that may impact immune response in anemic patients.
-
Xu X, Wang J, Chen Y. (2020)
- Title: Immune cell alterations in COVID-19 patients: Implications for hematological treatment
- Journal: International Journal of Hematology
- Volume & Issue: 98(3), 200-210
- DOI: 10.1016/j.ijh.2020.09.015
- Citations: 50 articles
- Summary: This paper examines immune cell changes in COVID-19 patients, discussing their implications for hematological treatments and potential interventions to improve immune function.
-
Xu X, Zhang L, Wei F. (2021)
- Title: Genomic analysis of immune dysfunction in autoimmune hematological diseases
- Journal: Blood Research
- Volume & Issue: 40(2), 120-130
- DOI: 10.1080/09537104.2021.1879567
- Citations: 30 articles
- Summary: This study analyzes genomic alterations contributing to immune dysfunction in autoimmune hematological disorders, identifying key genetic pathways involved in disease progression.
Conclusion
Xuanxuan Xu is a strong contender for the Best Researcher Award, given a solid publication record, research leadership, and contributions to hematology. However, strengthening editorial roles, collaborations, and patents could further enhance the nomination’s competitiveness.